LFG
FRTX

Larson Financial Group’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Larson Financial Group’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-160
Closed – – 1539
2022
Q3 		$0 Buy
+160
New +$463 ﹤0.01% 1428

Other funds holding FRTX

TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Larson Financial Group's FRTX Position: Q4 2022 in Review

Larson Financial Group sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2022, closing a stake of 160 shares.

Larson Financial Group first reported a position in FRTX in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 16 funds tracked by Wall St. Rank hold FRTX as of Q4 2022.

  • Larson Financial Group reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Larson Financial Group sold 160 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2022.
  • Larson Financial Group first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Larson Financial Group's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $0 in Q3 2022.
  • 16 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Larson Financial Group's 13F filing for Q4 2022, filed 3 Feb 2023.